Cargando…
Gene patents and personalized medicine - what lies ahead?
Gene patents have generally not impeded biomedical research, but some problems that arise in genetic diagnostics can be attributed to exclusively licensed gene patents. Gene patents for therapeutics have often been litigated but have received surprisingly little public outcry. In stark contrast, gen...
Autores principales: | Chandrasekharan, Subhashini, Cook-Deegan, Robert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768999/ https://www.ncbi.nlm.nih.gov/pubmed/19804612 http://dx.doi.org/10.1186/gm92 |
Ejemplares similares
-
The continuing saga of patents and non‐invasive prenatal testing
por: Hawkins, Naomi, et al.
Publicado: (2019) -
A Summary of 2018 and What Lies Ahead for Diabetes Therapy in 2019
por: Evans, Marc, et al.
Publicado: (2019) -
A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019
por: Fleischmann, Roy
Publicado: (2019) -
A Summary of 2018 and What Lies Ahead for Dermatology and Therapy in 2019
por: Menter, Alan, et al.
Publicado: (2019) -
Healthcare and medical education reforms in India: What lies ahead?
por: Kumar, Raman
Publicado: (2013)